Correlation Between Sweetgreen and Entero Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Sweetgreen and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sweetgreen and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sweetgreen and Entero Therapeutics,, you can compare the effects of market volatilities on Sweetgreen and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sweetgreen with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sweetgreen and Entero Therapeutics,.

Diversification Opportunities for Sweetgreen and Entero Therapeutics,

0.35

Correlation Coefficient

Sweetgreen  Entero Therapeutics,

Weak diversification

The 3 months correlation between Sweetgreen and Entero is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Sweetgreen and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Sweetgreen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sweetgreen are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Sweetgreen i.e., Sweetgreen and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Sweetgreen and Entero Therapeutics,

Allowing for the 90-day total investment horizon Sweetgreen is expected to generate 1.36 times less return on investment than Entero Therapeutics,. But when comparing it to its historical volatility, Sweetgreen is 3.25 times less risky than Entero Therapeutics,. It trades about 0.16 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  42.00  in Entero Therapeutics, on September 3, 2024 and sell it today you would earn a total of  5.00  from holding Entero Therapeutics, or generate 11.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sweetgreen  vs.  Entero Therapeutics,

Sweetgreen

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sweetgreen are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating technical and fundamental indicators, Sweetgreen reported solid returns over the last few months and may actually be approaching a breakup point.

Entero Therapeutics,

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sweetgreen and Entero Therapeutics,

The main advantage of trading using opposite Sweetgreen and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sweetgreen position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.

The idea behind Sweetgreen and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.